Risk-taking and setting financial goals (short-term and long-term) for investors from a neurosocial perspective based on testosterone measurements

Document Type : Original Article

Authors
1 PhD student, Department of Accounting, Damavand Branch, Islamic Azad University, Damavand, Iran.
2 Associate Professor,Department of Accounting, Damavand Branch, Islamic Azad University, Damavand, Iran.
10.30495/jik.2025.23668
Abstract
The purpose of this study was the effectiveness of investor behavior based on neural financial indicators in Iran. The research method is experimental with pre-test-post-test design with control group. In this plan, before the intervention, a pre-test was performed for the subjects to determine the behavior of investors (risk tolerance and financial goals), then testosterone was injected and four hours after the injection, a post-test was performed. The statistical population includes all accounting students of the Islamic Azad University of Tehran who have worked in the stock market for one year. Then, available at Azad University of Tehran, Markaz and Damavand Branches were selected as a sample and after screening, 80 people were selected as a sample and randomly assigned to two groups of 40 (experimental and control). Testosterone was injected intramuscularly for the experimental group and placebo (distilled water) was injected intramuscularly for the control group. The tool used to measure the behavior of investors is a researcher based on the research of Ramanojan and Silovarkomer (2018). The component of risk tolerance and financial goals (short-term and long-term) each had 8 items and the Likert scoring range is five degrees. In this paper, the extracted data were analyzed by analysis of covariance. The findings showed that testosterone increased investors' risk tolerance and made investors focus more on achievable (short-term) financial goals.
Keywords

برایان کلب، یان کیو ویشار و جی کیمپل تسکی(1399)، روانشناسی فیزیولوژیک(مغز و رفتار)، مترجم: مهرداد فیروزبخت، نوبت چاپ: اول، انتشارات آگاه.
صفری گرایلی، مهدی؛ رضائی پیته نوئی، یاسر و نوروزی، محمد (1396). سطح هورمون تستوسترون مدیر عامل و ریسک پذیری شرکت. فصلنامه علمی پژوهشی دانش سرمایه گذاری. سال ششم، شماره بیست و چهارم.
علی نژاد سراوکلائی، مهدی و رضایی، شبنم (1393). نقش هورمون‌های مغزی در تصمیم گیری سرمایه گذاران. اولین کنفرانس بین المللی اقتصاد، مدیریت، حسابداری و علوم اجتماعی. رشت.
نورائی، مریم؛ محمدی ملقرنی، عطااله؛ نوروش، ایرج و بهمن پور، کاوه (1400). ریسک پذیری و خوش بینی مدیران: تحلیل مدل مالی عصبی برمبنای سنجش هورمون‌ها. نشریه علمی حسابداری مدیریت، سال چهاردهم، شماره چهل و هشتم.
Apicella, C. L. (2011). “Androgens and competitiveness in men.” Journal of Neuroscience, Psychology, and Economics, Vol 4(1), Feb 2011, 54-62.
Apicella, C. L., Carré, J. M., & Dreber, A. (2015). Testosterone and economic risk taking: a review. Adaptive Human Behavior and Physiology, 1(3), 358-385.
Apicella, C. L., Dreber, A., Campbell, B., Gray, P. B., Hoffman, M., & Little, A. C. (2008). Testosterone and financial risk preferences. Evolution and human behavior, 29(6), 384-390.
Carre, J. M., Murphy, K. R., and Hariri, A. R. (2011). What Lies Beneath the Face of Aggression? Social Cognitive and Affective Neuroscience, 74(8), 350-358.
Chen, C. V., Brummet, J. L., Jordan, C. L., & Breedlove, S. M. (2016). Down, but not out: partial elimination of androgen receptors in the male mouse brain does not affect androgenic regulation of anxiety or HPA activity. Endocrinology, 157(2), 764-773.
Cueva, C., Roberts, R. E., Spencer, T., Rani, N., Tempest, M., Tobler, P. N., ... & Rustichini, A. (2015). Cortisol and testosterone increase financial risk taking and may destabilize markets. Scientific reports, 5(1), 1-16.
Cumming, D. C., & Wali, S. R. (1985). Non-sex hormone-binding globulin-bound testosterone as a marker for hyperandrogenism. The Journal of Clinical Endocrinology & Metabolism, 61(5), 873-876.
Jia, Y., L. van Lent, Y. Zeng, (2014). Testosterone and Financial Misreporting. SSRN eLibrary http://ssrn.com/abstract=2265510.
Kamiya, S., Kim, Y. and Suh, J. (2016). The Face of Risk: CEO Testosterone and Risk Taking Behavior. Available at SSRN: https://ssrn.com / abstract = 2557038 or http:// dx.doi.org /10.2139/ ssrn. 2557038.
Lefevre, C. E., G. J. Lewis, D. I. Perrett and L. Penke, (2013). “Telling facial metrics: facial width is associated with testosterone levels in men,” Evolution and Human Behavior, 34(4): 273 -279.
May, J. C., Delgado, M. R., Dahl, R. E., Stenger, V. A., Ryan, N. D., Fiez, J. A., & Carter, C. S. (2004). Event-related functional magnetic resonance imaging of reward-related brain circuitry in children and adolescents. Biological psychiatry, 55(4), 359-366.
Mills, J. (2014). CEO Facial Width Predicts Firm Financial Policies. Available at SSRN: https://ssrn.com / abstract = 2503582 or http: // dx.doi.org /10.2139 /ssrn.2503582.
Pound, N.; I. S. Penton - Voak and A. K. Surridge. (2009). “Testosterone responses to competition in men are related to facial masculinity.” Proceedings of the Royal Society B: Biological Sciences
Ronay, R., & Von Hippel, W. (2010). Power, testosterone, and risk‐taking. Journal of Behavioral Decision Making, 23(5), 473-482.
Sapienza, P., Zingales, L., & Maestripieri, D. (2009). Gender differences in financial risk aversion and career choices are affected by testosterone. Proceedings of the National Academy of Sciences, 106(36), 15268-15273.
Stirrat, M., and Perrett, D. I. (2010). Valid Facial Cues to Cooperation and Trust: Male Facial Width and Trustworthiness. Psychological Science, 21(1), 349–354.
Van Honk, J., Terbrg, D., and Bos, P. A. (2011). Further Notes on Testosterone as a Social Hormone. Trends in cognitive sciences, 15(15), 291-292.
Weston, E. M., Friday, A. E. and Lio, P. (2007). Biometric Evidence that Sexual Selection Has Shaped the Hominine Face. PLoS ONE. http://dx.doi.org/10.1371/journal.pone.0000710.
White, K., Watkins, K., McCoy, M., Muruthi, B., & Byram, J. L. (2021). How Financial Socialization Messages Relate to Financial Management, Optimism and Stress: Variations by Race. Journal of Family and Economic Issues, 42(2), 237-250.